SCHEMBL21138531

SCHEMBL21138531

O=C1CC(C(=O)O)[C@@H](c2ccc(F)cc2)N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.40
GAA P10253 4/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GSK3B P49841 1/20 0.38
BACE1 P56817 1/20 0.38
MMP1 P03956 1/20 0.36
MMP13 P45452 1/20 0.36
TP53 P04637 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 1/20 0.35
SLC9A1 P19634 1/20 0.35
APAF1 O14727 1/20 0.35
POLB P06746 1/20 0.35
GRK2 P25098 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
LMNA P02545 2/20 0.35
PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21104519 1.00 TDP1 (0.40) TDP1GAAALDH1A1KDM4EGSK3B
SCHEMBL21057907 1.00 TDP1 (0.40) TDP1GAAALDH1A1KDM4EGSK3B
SCHEMBL29508338 1.00 TDP1 (0.40) TDP1GAAALDH1A1KDM4EGSK3B
SCHEMBL2800532 0.89 LMNA (0.37) TDP1GAAALDH1A1KDM4EGSK3B
SCHEMBL21057926 0.85 LMNA (0.40) GAAALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21138517 0.85 LMNA (0.40) GAAALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21057929 0.85 LMNA (0.40) GAAALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21057931 0.85 LMNA (0.40) GAAALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21057971 0.84 ITGB3 (0.33) ALDH1A1POLBLMNA
SCHEMBL21057975 0.84 ITGB3 (0.33) ALDH1A1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190185455-A1 Substituted Pyrrolidine Amides I GRUENENTHAL GMBH (DE) 2019-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190185455-A1 Substituted Pyrrolidine Amides I NR3C1, NR3C2, NR5A1 TDP1 3265/4885GAA 3526/4885ALDH1A1 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.